Cardiol Therapeutics Inc. (CRDL.TO)

CAD 1.38

(-1.43%)

Total Assets Summary of Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.'s latest annual total assets in 2023 was 36.7 Million CAD , down -40.83% from previous year.
Cardiol Therapeutics Inc.'s latest quarterly total assets in 2024 Q2 was 26.31 Million CAD , down -15.46% from previous quarter.
Cardiol Therapeutics Inc. reported annual total assets of 62.02 Million CAD in 2022, down -29.41% from previous year.
Cardiol Therapeutics Inc. reported annual total assets of 87.87 Million CAD in 2021, up 452.92% from previous year.
Cardiol Therapeutics Inc. reported quarterly total assets of 31.12 Million CAD for 2024 Q1, down -15.19% from previous quarter.
Cardiol Therapeutics Inc. reported quarterly total assets of 36.7 Million CAD for 2023 Q4, down -14.76% from previous quarter.

Annual Total Assets Chart of Cardiol Therapeutics Inc. (2023 - 2017)

Historical Annual Total Assets of Cardiol Therapeutics Inc. (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	36.7 Million CAD	-40.83%
2022	62.02 Million CAD	-29.41%
2021	87.87 Million CAD	452.92%
2020	15.89 Million CAD	2.52%
2019	15.5 Million CAD	-37.2%
2018	24.68 Million CAD	666.45%
2017	3.22 Million CAD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	26.31 Million CAD	-15.46%
2024 Q1	31.12 Million CAD	-15.19%
2023 Q4	36.7 Million CAD	-14.76%
2023 Q2	47.16 Million CAD	-10.47%
2023 Q1	52.68 Million CAD	-15.06%
2023 FY	36.7 Million CAD	-40.83%
2023 Q3	43.05 Million CAD	-8.73%
2022 Q2	74.26 Million CAD	-6.51%
2022 Q4	62.02 Million CAD	-9.26%
2022 FY	62.02 Million CAD	-29.41%
2022 Q1	79.43 Million CAD	-9.61%
2022 Q3	68.35 Million CAD	-7.95%
2021 Q1	21.09 Million CAD	32.75%
2021 FY	87.87 Million CAD	452.92%
2021 Q4	87.87 Million CAD	176.94%
2021 Q3	31.73 Million CAD	-13.65%
2021 Q2	36.74 Million CAD	74.19%
2020 Q1	13.35 Million CAD	-13.88%
2020 FY	15.89 Million CAD	2.52%
2020 Q4	15.89 Million CAD	-35.01%
2020 Q3	24.45 Million CAD	-10.82%
2020 Q2	27.42 Million CAD	105.38%
2019 Q4	15.5 Million CAD	-15.3%
2019 Q2	20.53 Million CAD	-10.38%
2019 Q1	22.91 Million CAD	-7.17%
2019 FY	15.5 Million CAD	-37.2%
2019 Q3	18.3 Million CAD	-10.87%
2018 Q4	24.68 Million CAD	88.52%
2018 Q1	- CAD	-100.0%
2018 Q2	12.14 Million CAD	0.0%
2018 FY	24.68 Million CAD	666.45%
2018 Q3	13.09 Million CAD	7.82%
2017 FY	3.22 Million CAD	0.0%
2017 Q4	3.22 Million CAD	0.0%

Peer Total Assets Comparison of Cardiol Therapeutics Inc.

Name	Total Assets	Total Assets Difference
Aurora Cannabis Inc.	838.67 Million CAD	95.624%
Avicanna Inc.	21.97 Million CAD	-67.04%
Avant Brands Inc.	82.55 Million CAD	55.543%
Crescita Therapeutics Inc.	24.59 Million CAD	-49.201%
Knight Therapeutics Inc.	945.49 Million CAD	96.118%
MediPharm Labs Corp.	63.93 Million CAD	42.599%
OrganiGram Holdings Inc.	298.45 Million CAD	87.703%
Canopy Growth Corporation	1.3 Billion CAD	97.178%
Willow Biosciences Inc.	6.67 Million CAD	-449.985%
Auxly Cannabis Group Inc.	261.9 Million CAD	85.987%